Tag: Cinryze

March 16, 2017 Off

Shire gets European approval for Llabel extension of Cinryze

By Dino Mustafić

Shire said on Thursday that the European Commission (EC) has approved a label extension granting three new indications for CINRYZE® (C1 inhibitor [human]), broadening its use to children with Hereditary angiodema (HAE), a rare, genetic disorder that results in recurring attacks of edema (swelling). The body sites most commonly affected are mainly the extremities and abdomen.